IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / November 1, 2016 / Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Neos Therapeutics, Inc. (“Neos” or the “Company”) (NASDAQ: NEOS) concerning possible violations of federal securities laws.

If you purchased shares of Neos and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

The investigation focuses on the August 11, 2016 announcement of Neos’ financial results for the second quarter of 2016, reporting that it missed its earnings expectations by $0.49 per share. When this information was disclosed, shares of Neos fell in value.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 448124